Drawing for CP CRANBURY PHARMACEUTICALS

USPTO serial 88418271

CP CRANBURY PHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SABAGH, LAILA TAREK
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CP CRANBURY PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CATHY KODROFF

CATHY KODROFF Howson & Howson LLP325 Sentry Parkway EastFive Sentry East, Ste 160Blue Bell, PA 19422

Goods and services

ClassDescriptionStatusFirst use
005Prescription and non-prescription pharmaceutical medicines and preparations for the treatment of cold and allergy symptoms, respiratory disease, asthma and chronic lung disease, upper respiratory symptoms, coughs, central nervous system disorders, namely, narcolepsy and attention deficit hyperactivity disorder, for the treatment of autism, schizophrenia, bipolar disorder, convulsions, epilepsy, nausea, vomiting, pruritus, for inducing sedation, for pain relief, and for anti-inflammation; dietary supplements; nutritional supplements; vitamins; nutritional supplements in the nature of nutriceuticals for use in treating nutritional deficiencies and as dietary supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 26, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 25, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 18, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 17, 2023EX5GSOU EXTENSION 5 GRANTED—
May 12, 2023EXT5SOU EXTENSION 5 FILED—
May 12, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 3, 2022EX4GSOU EXTENSION 4 GRANTED—
Nov 3, 2022EXT4SOU EXTENSION 4 FILED—
Nov 3, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 29, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 27, 2022EX3GSOU EXTENSION 3 GRANTED—
Apr 27, 2022EXT3SOU EXTENSION 3 FILED—
Apr 27, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 25, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 23, 2021EX2GSOU EXTENSION 2 GRANTED—
Nov 23, 2021EXT2SOU EXTENSION 2 FILED—
Nov 23, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 23, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 22, 2021EX1GSOU EXTENSION 1 GRANTED—
Jun 22, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 27, 2021NREVNOTICE OF REVIVAL - E-MAILED—
May 27, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
May 27, 2021PETGPETITION TO REVIVE-GRANTED—
May 27, 2021PROATEAS PETITION TO REVIVE RECEIVED—
May 24, 2021EXT1SOU EXTENSION 1 FILED—
Nov 24, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 29, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 29, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 9, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 25, 2020EXPTEXPARTE APPEAL TERMINATED—
Aug 25, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 20, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 20, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 18, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 18, 2020EXPIEX PARTE APPEAL-INSTITUTED—
Aug 18, 2020JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Aug 18, 2020EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Feb 19, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 19, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 19, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 29, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 29, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 29, 2020ALIEASSIGNED TO LIE—
Jan 23, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 25, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 25, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 25, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 25, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 22, 2019DOCKASSIGNED TO EXAMINER—
May 23, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 22, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 10, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance